8-K: Abpro Faces Nasdaq Delisting Threat

Sentiment:

Delisting Notice


Abpro Holdings, Inc. received a delisting notice from Nasdaq for failing to meet the minimum bid price requirement, but plans to appeal.

Worse than expectedThe company failed to meet Nasdaq's minimum bid price requirement of $1.00 per share.Abpro received a formal notice of non-compliance and a scheduled delisting date, indicating a significant setback in its listing status.

Summary

  • Abpro Holdings, Inc. (ABP) received a notice from Nasdaq on September 30, 2025, indicating non-compliance with the minimum bid price requirement.
  • The company failed to maintain a minimum bid price of $1.00 per share, as required by Nasdaq Listing Rule 5450(a)(1), during the 180-calendar-day compliance period that ended on September 29, 2025.
  • Unless an appeal is requested by October 7, 2025, the company's common stock is scheduled for delisting at the opening of business on October 9, 2025.
  • Abpro intends to timely request a hearing before the Nasdaq appeal panel, which will stay the suspension of its securities pending the panel's decision.
  • During the hearing, the company plans to present its strategy to regain compliance with the bid price and other listing requirements.

Sentiment

Score: 2

Explanation: The sentiment is highly negative due to the company's failure to meet Nasdaq's minimum bid price requirement and the imminent threat of delisting. While an appeal is planned, the outcome is uncertain, posing significant risk to shareholders.

Positives

  • The company intends to timely request a hearing before the Nasdaq appeal panel.
  • Requesting a hearing will temporarily stay the suspension of the company's securities on Nasdaq, allowing continued trading during the appeal process.

Negatives

  • Abpro Holdings, Inc. failed to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
  • The company received a notice on September 30, 2025, indicating its common stock is scheduled for delisting if an appeal is not filed by October 7, 2025.

Risks

  • There is no assurance that the Nasdaq appeal panel will grant the company's request for continued listing.
  • The company may not be able to evidence compliance with listing requirements prior to the expiration of any extension granted by the panel.
  • Failure to regain compliance could lead to the delisting of the company's common stock from Nasdaq.

Future Outlook

The company intends to appeal Nasdaq's delisting determination and present a plan to regain compliance with the minimum bid price and all other continued listing requirements. However, there is no guarantee that the appeal will be successful or that the company will be able to achieve compliance within any granted extension period.

Management Comments

  • Miles Suk, Chief Executive Officer, signed the report on behalf of Abpro Holdings, Inc.

Industry Context

Delisting notices due to minimum bid price non-compliance are common for smaller biotechnology or emerging growth companies, particularly during challenging market conditions or after significant stock price declines. Such events can severely impact investor confidence and access to capital.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Listing Compliance IssueFailure to comply with Nasdaq Listing Rule 5450(a)(1) requiring a minimum bid price of $1.00 per share.2025-09-30This non-compliance threatens the company's listing on Nasdaq, potentially impacting liquidity, investor confidence, and access to capital markets. The company's intent to appeal will temporarily stay the delisting process.

Stakeholder Impact

  • Shareholders: Face significant risk of delisting, which could lead to reduced liquidity, lower stock price, and potential transfer to over-the-counter markets.
  • Investors: May lose confidence in the company's ability to maintain its public listing and access capital markets.
  • Employees: Potential uncertainty regarding the company's future and financial stability.

Next Steps

  • Timely request a hearing before the Nasdaq appeal panel by October 7, 2025.
  • Present plans to regain compliance with the bid price and all other continued listing requirements during the appeal hearing.
  • Await the Nasdaq appeal panel's decision regarding continued listing or any granted extension.

Key Dates

DateDescription
2025-04-02Abpro Holdings, Inc. received initial written notice from Nasdaq regarding non-compliance with the minimum bid price requirement.
2025-09-29End of the 180-calendar-day compliance period for the minimum bid price requirement.
2025-09-30Abpro Holdings, Inc. received a letter from Nasdaq notifying the company of its failure to regain compliance with the minimum bid price requirement.
2025-10-03Date of signing the Current Report on Form 8-K by Miles Suk, CEO.
2025-10-07Deadline for the company to request an appeal before the Nasdaq appeal panel.
2025-10-09Scheduled date for delisting of the company's common stock at the opening of business, if no appeal is requested.

Recommendation

hold

A 'hold' recommendation is issued with extreme caution. While the immediate threat of delisting is significant, the company's intent to appeal provides a temporary stay and an opportunity to present a plan for compliance. Investors should closely monitor the outcome of the appeal process and any subsequent actions taken by management to regain compliance. The risk of delisting remains high, and further downside is possible if the appeal is unsuccessful or compliance is not achieved.

Keywords

Nasdaq, Delisting, Minimum Bid Price, Compliance, Appeal, Abpro Holdings, ABP, Corporate Governance, Stock Market

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.